Skip to main content

Table 1 Patients characteristics

From: Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients

Variable

Patients (n = 100)

Gender, n (%), female/male

47 (47)/53 (53)

Age, years, median (range)

62 (28–90)

LDH, n (%)

 Normal

60 (60)

 Elevated

34 (34)

 Unknown

6 (6)

B-RAF, n (%)

 Mutation

43 (43)

 Wild-type

54 (54)

 Unknown

3 (3)

 Brain metastasis, n (%)

28 (28)

M category (AJCC), n (%)

 M0

2 (2)

 M1a

8 (8)

 M1b

12 (12)

 M1c

78 (78)

Line of treatment, n (%)

 First line

27 (27)

 > 2

73 (73)